Robinson P J
Endocrine Unit, John Hunter Hospital, NSW, Australia.
Mol Neurobiol. 1991;5(2-4):87-130. doi: 10.1007/BF02935541.
This article focuses on the role of protein phosphorylation, especially that mediated by protein kinase C (PKC), in neurotransmitter release. In the first part of the article, the evidence linking PKC activation to neurotransmitter release is evaluated. Neurotransmitter release can be elicited in at least two manners that may involve distinct mechanisms: Evoked release is stimulated by calcium influx following chemical or electrical depolarization, whereas enhanced release is stimulated by direct application of phorbol ester or fatty acid activators of PKC. A markedly distinct sensitivity of the two pathways to PKC inhibitors or to PKC downregulation suggests that only enhanced release is directly PKC-mediated. In the second part of the article, a framework is provided for understanding the complex and apparently contrasting effects of PKC inhibitors. A model is proposed whereby the site of interaction of a PKC inhibitor with the enzyme dictates the apparent potency of the inhibitor, since the multiple activators also interact with these distinct sites on the enzyme. Appropriate PKC inhibitors can now be selected on the basis of both the PKC activator used and the site of inhibitor interaction with PKC. In the third part of the article, the known nerve terminal substrates of PKC are examined. Only four have been identified, tyrosine hydroxylase, MARCKS, B-50, and dephosphin, and the latter two may be associated with neurotransmitter release. Phosphorylation of the first three of these proteins by PKC accompanies release. B-50 may be associated with evoked release since antibodies delivered into permeabilized synaptosomes block evoked, but not enhanced release. Dephosphin and its PKC phosphorylation may also be associated with evoked release, but in a unique manner. Dephosphin is a phosphoprotein concentrated in nerve terminals, which, upon stimulation of release, is rapidly dephosphorylated by a calcium-stimulated phosphatase (possibly calcineurin [CN]). Upon termination of the rise in intracellular calcium, dephosphin is phosphorylated by PKC. A priming model of neurotransmitter release is proposed where PKC-mediated phosphorylation of such a protein is an obligatory step that primes the release apparatus, in preparation for a calcium influx signal. Protein dephosphorylation may therefore be as important as protein phosphorylation in neurotransmitter release.
本文聚焦于蛋白质磷酸化,尤其是蛋白激酶C(PKC)介导的磷酸化在神经递质释放中的作用。在文章的第一部分,评估了将PKC激活与神经递质释放联系起来的证据。神经递质释放至少可以通过两种可能涉及不同机制的方式引发:诱发释放是在化学或电去极化后由钙内流刺激的,而增强释放是由直接应用佛波酯或PKC的脂肪酸激活剂刺激的。这两条途径对PKC抑制剂或PKC下调的显著不同敏感性表明,只有增强释放是直接由PKC介导的。在文章的第二部分,提供了一个框架来理解PKC抑制剂的复杂且明显相反的作用。提出了一个模型,据此PKC抑制剂与该酶的相互作用位点决定了抑制剂的表观效力,因为多种激活剂也与该酶上的这些不同位点相互作用。现在可以根据所使用的PKC激活剂以及抑制剂与PKC的相互作用位点来选择合适的PKC抑制剂。在文章的第三部分,研究了已知的PKC的神经末梢底物。仅鉴定出了四种,即酪氨酸羟化酶、MARCKS、B - 50和去磷酸蛋白,后两者可能与神经递质释放有关。PKC对这些蛋白质中前三种的磷酸化伴随着释放。B - 50可能与诱发释放有关,因为导入通透突触体的抗体可阻断诱发释放,但不能阻断增强释放。去磷酸蛋白及其PKC磷酸化也可能与诱发释放有关,但方式独特。去磷酸蛋白是一种集中在神经末梢的磷蛋白,在释放受到刺激时,它会被钙刺激的磷酸酶(可能是钙调神经磷酸酶[CN])迅速去磷酸化。在细胞内钙升高终止后,去磷酸蛋白会被PKC磷酸化。提出了一个神经递质释放的引发模型,其中PKC介导的此类蛋白质的磷酸化是引发释放装置的一个必要步骤,为钙内流信号做准备。因此,蛋白质去磷酸化在神经递质释放中可能与蛋白质磷酸化同样重要。